These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30716942)

  • 1. Synbiotic meal decreases uremic toxins in hemodialysis individuals: A placebo-controlled trial.
    Lopes RCSO; Theodoro JMV; da Silva BP; Queiroz VAV; de Castro Moreira ME; Mantovani HC; Hermsdorff HH; Martino HSD
    Food Res Int; 2019 Feb; 116():241-248. PubMed ID: 30716942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Symbiotic Meal Containing Extruded Sorghum and Probiotic (
    Lúcio HG; Lopes RCSO; Gomes MJC; da Silva A; Grancieri M; Della Lucia CM; Queiroz VAV; da Silva BP; Martino HSD
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotic Supplementation in Chronic Kidney Disease: A Double-blind, Randomized, Placebo-controlled Trial.
    Borges NA; Carmo FL; Stockler-Pinto MB; de Brito JS; Dolenga CJ; Ferreira DC; Nakao LS; Rosado A; Fouque D; Mafra D
    J Ren Nutr; 2018 Jan; 28(1):28-36. PubMed ID: 28888762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
    Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study.
    Salarolli RT; Alvarenga L; Cardozo LFMF; Teixeira KTR; de S G Moreira L; Lima JD; Rodrigues SD; Nakao LS; Fouque D; Mafra D
    Int Urol Nephrol; 2021 Jun; 53(6):1231-1238. PubMed ID: 33438085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.
    Deltombe O; Van Biesen W; Glorieux G; Massy Z; Dhondt A; Eloot S
    Toxins (Basel); 2015 Sep; 7(10):3933-46. PubMed ID: 26426048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients?
    Eloot S; Van Biesen W; Glorieux G; Neirynck N; Dhondt A; Vanholder R
    PLoS One; 2013; 8(11):e76838. PubMed ID: 24236005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Synbiotic Treatment on the Levels of Gut-Derived Uremic Toxins, Inflammation, and Gut Microbiome of Chronic Kidney Disease Patients-A Randomized Trial.
    Mitrović M; Stanković-Popović V; Tolinački M; Golić N; Soković Bajić S; Veljović K; Nastasijević B; Soldatović I; Svorcan P; Dimković N
    J Ren Nutr; 2023 Mar; 33(2):278-288. PubMed ID: 35995418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors of microinflammation in non-diabetic chronic kidney disease: a pilot study.
    Olivier V; Dunyach-Remy C; Corbeau P; Cristol JP; Sutra T; Burtey S; Lavigne JP; Moranne O
    BMC Nephrol; 2020 Apr; 21(1):141. PubMed ID: 32316931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of synbiotic supplementation on microbiota-derived protein-bound uremic toxins, systemic inflammation, and biochemical parameters in patients on hemodialysis: A double-blind, placebo-controlled, randomized clinical trial.
    Mirzaeian S; Saraf-Bank S; Entezari MH; Hekmatdoost A; Feizi A; Atapour A
    Nutrition; 2020 May; 73():110713. PubMed ID: 32120316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-Cresol Sulfate in Hemodialysis Patients: Results From an In Vitro Study and An In Vivo Pilot Trial (xuanro4-Nature 3.2).
    Rocchetti MT; Cosola C; di Bari I; Magnani S; Galleggiante V; Scandiffio L; Dalfino G; Netti GS; Atti M; Corciulo R; Gesualdo L
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32164382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations among total p-cresylsulfate, indoxyl sulfate and hippuric acid levels with hemodialysis quality indicators in maintenance hemodialysis patients.
    Lu YC; Wu CC; Tsai IT; Hung WC; Lee TL; Hsuan CF; Yu TH; Wei CT; Chung FM; Lee YJ; Wang CP
    Clin Chim Acta; 2021 May; 516():83-91. PubMed ID: 33508250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Synbiotic Supplementation on Uremic Toxins, Oxidative Stress, and Inflammation in Hemodialysis Patients-Results of an Uncontrolled Prospective Single-Arm Study.
    Kuskunov T; Tilkiyan E; Doykov D; Boyanov K; Bivolarska A; Hristov B
    Medicina (Kaunas); 2023 Jul; 59(8):. PubMed ID: 37629672
    [No Abstract]   [Full Text] [Related]  

  • 16. pH-Dependent Protein Binding Properties of Uremic Toxins In Vitro.
    Yamamoto S; Sasahara K; Domon M; Yamaguchi K; Ito T; Goto S; Goto Y; Narita I
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33557434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Transport of Protein-Bound Uremic Toxins in Erythrocytes.
    Deltombe O; Glorieux G; Marzouki S; Masereeuw R; Schneditz D; Eloot S
    Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31266243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there an association between the plasma levels of uremic toxins from gut microbiota and anemia in patients on hemodialysis?
    Capo-Chichi JCC; Borges NA; de Vargas Reis DCM; Nakao LS; Mafra D
    Int Urol Nephrol; 2022 Jun; 54(6):1271-1277. PubMed ID: 34561817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis.
    Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
    J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients.
    Bataille S; Pelletier M; Sallée M; Berland Y; McKay N; Duval A; Gentile S; Mouelhi Y; Brunet P; Burtey S
    BMC Nephrol; 2017 Jul; 18(1):251. PubMed ID: 28747155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.